Bayer Launches FDA-Approved Soft Chew for Canine Osteoarthritis Pain Management
Bayer HealthCare LLC Animal Health is pleased to announce the launch of quellin (carprofen) soft chewable tablets to help alleviate the pain associated with canine osteoarthritis, one of the most common causes of chronic pain in dogs-affecting 20 percent of dogs older than one year of age. quellin, the first FDA-approved, meat flavored, soft chew osteoarthritis pain therapy for dogs, is designed to be easily accepted by dogs and provide pet owners with an easier method of administering the drug at home-most dogs readily take it right out of their hands, so there is no need for additional delivery aids, like pill pouches.
quellin is the first soft chewable formulation of carprofen, the leading veterinarian-prescribed, non-steroidal anti-inflammatory drug (NSAID) for dogs. Formulated using patented soft chew technology from Bayer, the active ingredient is evenly distributed throughout each chew, which is given in half-tablet increments-and each chew is scored to aid in accurate dosing. These features, combined with a savory meat flavor, contain no animal proteins, and help deliver the dose prescribed for each patient without the need for additional delivery aids like pill pouches.
"Bayer's introduction of quellin provides veterinarians with a precise, savory and easy-to-use therapy that helps treat the pain and inflammation of canine osteoarthritis," said Cristiano von Simson, DVM, MBA, director, Veterinary Services, Bayer HealthCare LLC Animal Health. "Administering hard tablets can be difficult for some dog owners. This soft and tasty chew is easy to give and may encourage at-home compliance with prescribed dosing regimens." quellinT is available in 25 mg, 75 mg and 100 mg soft chew tablets veterinary prescription only. quellin may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb twice daily.